Impact of a Short Psychoeducation Program on Patients with Early Schizophrenia
Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia
This study tests if a short educational program can help people with early schizophrenia better understand their condition and improve their treatment experience.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nice Academic / other |
| Locations | 1 site (Nice) |
| Trial ID | NCT04867681 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of a brief psychoeducation program on the therapeutic alliance in patients experiencing their first or second acute psychotic episode related to schizophrenia. The program aims to enhance understanding and management of the condition, potentially improving patient outcomes. Participants will be French-speaking individuals hospitalized for their acute episodes, and the study will assess the impact of early psychoeducation on their treatment journey. The approach is based on the premise that early intervention can lead to better long-term prognoses for schizophrenia.
Who should consider this trial
Good fit: Ideal candidates are French-speaking individuals experiencing their first or second acute psychotic episode related to schizophrenia.
Not a fit: Patients under guardianship, participating in another study, or hospitalized under restraint may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the therapeutic relationship and overall treatment outcomes for patients with early schizophrenia.
How similar studies have performed: Previous studies have shown that early psychoeducation can positively impact treatment outcomes in schizophrenia, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * French speaking * Presenting a first or second acute psychotic episode, corresponding according to DSM 5 criteria to: * A brief psychotic disorder * And/or a schizophrenic disorder evolving for less than 2 years, * Hospitalized in full time or in day care, * Understanding and accepting the constraints of the study, Exclusion Criteria: * Patient under guardianship * Patient participating in another study * Patient in hospital under restraint
Where this trial is running
Nice
- CHU de Nice — Nice, France (Recruiting)
Study contacts
- Study coordinator: Bruno GIORDANA, Dr
- Email: giordana.b@chu-nice.fr
- Phone: 4 92 03 87 75
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.